Comparison of dosimetric verification results and plan complexity for treatment plans generated in Ethos 1.0 and Ethos 2.0 systems

INTRODUCTION: The Varian Ethos adaptive radiotherapy system was upgraded from version 1.0 to 2.0, introducing an enhanced multi-leaf collimator (MLC) dose calculation model and a new optimization engine. We evaluated whether this affected agreement between calculated and measured dose, and plan complexity. MATERIAL AND METHODS: Twenty-four plans (14 intensity-modulated radiotherapy [IMRT], 10 volumetric modulated arc therapy [VMAT]; 26 measurement configurations) covering 10 anatomical sites were analyzed in three matched configurations: original Ethos 1.0 plans (E1.0), the same plans recalculated in Ethos 2.0 with the new MLC model only (E1.0→2.0), and plans re-optimized in Ethos 2.0 (E2.0). Quality assurance comprised ionization chamber point-dose measurement and global gamma analysis on an ArcCHECK array at 3%/3 mm, 3%/2 mm and 2%/2 mm (10% threshold). Complexity was quantified with UCoMX v1.1; groups were compared with the Wilcoxon signed-rank test. RESULTS: Mean signed chamber deviation was -1.59 ± 0.54% (E1.0), -1.54 ± 0.57% (E1.0→2.0) and -1.39 ± 0.63% (E2.0), with no significant differences (p > 0.6); all met the ±3% criterion. Gamma pass rates at 3%/3 mm were 99.2 ± 0.9%, 98.7 ± 1.0% (p < 0.001) and 98.6 ± 2.1% (p = 0.059). Re-optimized plans used 12% fewer monitor units (1,169 ± 395 vs. 1,338 ± 471, p < 0.001) and were simpler (MCSv 0.31 to 0.35; SAS10 mm 0.27 to 0.20; both p < 0.001). CONCLUSION: The upgrade preserved quality-assurance compliance and produced simpler, lower--monitor-unit plans, but the systematic -1.5% offset between calculated and measured point dose persisted, showing the new MLC model alone does not remove it.

Authors

Institutions

Publication Details

Journal
Acta Oncologica
Published
2026-11-18
DOI
https://doi.org/10.2340/1651-226x.2026.46866
Primary Topic
Advanced Radiotherapy Techniques
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comparison of dosimetric verification results and plan complexity for treatment plans generated in Ethos 1.0 and Ethos 2.0 systems

Mikolaj Tarchalski, Marta Fillmann, Paulina Wesolowska, Anna Paciorkiewicz et al.
2 links
Acta Oncologica
Advanced Radiotherapy Techniques
article

Comparison of dosimetric verification results and plan complexity for treatment plans generated in Ethos 1.0 and Ethos 2.0 systems

Mikolaj Tarchalski, Marta Fillmann, Paulina Wesolowska, Anna Paciorkiewicz, Agnieszka Walewska, J. Iwanowska, Bartlomiej Sadowski, Sandra Maluszczak
article en

Abstract

INTRODUCTION: The Varian Ethos adaptive radiotherapy system was upgraded from version 1.0 to 2.0, introducing an enhanced multi-leaf collimator (MLC) dose calculation model and a new optimization engine. We evaluated whether this affected agreement between calculated and measured dose, and plan complexity. MATERIAL AND METHODS: Twenty-four plans (14 intensity-modulated radiotherapy [IMRT], 10 volumetric modulated arc therapy [VMAT]; 26 measurement configurations) covering 10 anatomical sites were analyzed in three matched configurations: original Ethos 1.0 plans (E1.0), the same plans recalculated in Ethos 2.0 with the new MLC model only (E1.0→2.0), and plans re-optimized in Ethos 2.0 (E2.0). Quality assurance comprised ionization chamber point-dose measurement and global gamma analysis on an ArcCHECK array at 3%/3 mm, 3%/2 mm and 2%/2 mm (10% threshold). Complexity was quantified with UCoMX v1.1; groups were compared with the Wilcoxon signed-rank test. RESULTS: Mean signed chamber deviation was -1.59 ± 0.54% (E1.0), -1.54 ± 0.57% (E1.0→2.0) and -1.39 ± 0.63% (E2.0), with no significant differences (p > 0.6); all met the ±3% criterion. Gamma pass rates at 3%/3 mm were 99.2 ± 0.9%, 98.7 ± 1.0% (p < 0.001) and 98.6 ± 2.1% (p = 0.059). Re-optimized plans used 12% fewer monitor units (1,169 ± 395 vs. 1,338 ± 471, p < 0.001) and were simpler (MCSv 0.31 to 0.35; SAS10 mm 0.27 to 0.20; both p < 0.001). CONCLUSION: The upgrade preserved quality-assurance compliance and produced simpler, lower--monitor-unit plans, but the systematic -1.5% offset between calculated and measured point dose persisted, showing the new MLC model alone does not remove it.

Acta OncologicaVol. 65
National Institute of Oncology (HU), The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
Good health and well-being
Advanced Radiotherapy Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon